MetAlert

MetAlert (OTC: MLRT) is known for designing, manufacturing, distributing, and licensing products and intellectual property in the GPS/BLE wearable technology, personal location, and health data collection and monitoring fields. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for patients afflicted with Alzheimer, dementia, and autism. The company offers connectivity solutions which seamlessly integrate with consumer, enterprise and government applications. Best known for its award-winning patented GPS SmartSole® — think Dr. Scholl’s meets LoJack- tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. Other customers include public health authorities, military entities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, and senior care homes. www.metalert.com